PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPostoperative nausea and vomiting
MeSH D020250 - postoperative nausea and vomiting
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014839:Vomiting
148 Companies
39 Drugs
$
Success rate
D009325:Nausea
144 Companies
39 Drugs
$
Success rate
D011183:Postoperative complications
92 Companies
18 Drugs
$
Success rate
D020250: 
Postoperative nausea and vomiting
29 Companies
3 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Salix PharmaceuticalsMetoclopramide Metozolv  2009-09-04   
TevaMetoclopramide Metoclopramide  1985-07-29   
SandozMetoclopramide Metoclopramide  1987-02-03   
King PharmaceuticalsMetoclopramide Maxolon  1986-03-04   
Merck & CoAprepitant Emend  2003-11-11 $145 M Y2020 
Metoclopramide Metoclopramide  1987-02-02   
Sun Pharmaceutical IndustriesMetoclopramide Metoclopramide  1993-04-28   
HospiraMetoclopramide Metoclopramide  1989-06-23   
AiPing PharmaceuticalMetoclopramide Metoclopramide  1990-01-30   
Chartwell PharmaceuticalsMetoclopramide Metoclopramide  1992-10-27   
Impax LaboratoriesMetoclopramide Metoclopramide  1988-02-03   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%
12/12
Phase 2
78%
29/37
Phase 3
85%
29/34
Approved: 3Overall Success rate: 67%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Merck & Co
Aprepitant,
Metoclopramide,
Benzodiazepine,
Ramosetron,
Aspartame,
Nadide,
Nepidermin,
Butylscopolamine bromide,
Atropa belladonna,
Kwells,
Ramosetron hydrochloride
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use